Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction

Abstract Background Microvascular obstruction (MVO) develops in approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI) after undergoing percutaneous coronary intervention (PCI). MVO is strongly linked to inflammation, myocardial fibrosis, and adverse clinical outcomes....

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Xinjia Du, Jiahua Liu, Jingfang Zhou, Yanfei Ren, Nauman Gul, Lei Chen, Yuan Lu
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2024-11-01
סדרה:	BMC Cardiovascular Disorders
נושאים:	Microvascular obstruction Soluble suppression of tumorigenicity 2 Myocardial infarction Cardiovascular magnetic resonance
גישה מקוונת:	https://doi.org/10.1186/s12872-024-04364-2
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!